{"status": "ok", "totalResults": 2, "articles": [{"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Gloria Li, Gary Jones", "title": "Live news: Yen slides as Bank of Japan maintains ultra-low interest rate policy - Financial Times", "description": "News, analysis and comment from the Financial Times, the world\u02bcs leading global business publication", "url": "https://www.ft.com/content/8dd95266-f8ee-4f8a-b504-2df3f9dc0b11", "urlToImage": null, "publishedAt": "2023-09-22T04:21:00Z", "content": "What is included in my trial?\r\nDuring your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.\r\nStandard Digital includ\u2026 [+1496 chars]"}, {"source": {"id": null, "name": "Astrazeneca.com"}, "author": null, "title": "Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial - AstraZeneca", "description": "", "url": "https://www.astrazeneca.com/media-centre/press-releases/2023/dato-dxd-improved-pfs-in-breast-cancer.html", "urlToImage": "", "publishedAt": "2023-09-22T01:30:00Z", "content": "Positive high-level results from the TROPION-Breast01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant and clinically meaningful improvement for the p\u2026 [+9913 chars]"}]}